M V22 (Hydrochlorothiazide and Valsartan 12.5 mg / 160 mg)
Pill with imprint M V22 is Orange, Round and has been identified as Hydrochlorothiazide and Valsartan 12.5 mg / 160 mg. It is supplied by Mylan Pharmaceuticals Inc.
Hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/valsartan 12.5 mg / 160 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M V22
- M V22
- 12.5 mg / 160 mg
- 10.00 mm
- Prescription only
- Drug Class
- Angiotensin II inhibitors with thiazides
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
ferric oxide red,
ferric oxide yellow,
sodium lauryl sulfate,
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00378-6322||Mylan Pharmaceuticals Inc.|
|51079-0193 (Discontinued)||UDL Laboratories Inc.|
More about hydrochlorothiazide / valsartan
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (24)
- Drug images
- Pricing & coupons
- En español
- Drug class: angiotensin II inhibitors with thiazides
- Drug Information
- Valsartan and hydrochlorothiazide (Advanced Reading)
- Valsartan and Hydrochlorothiazide
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.